Clinical Trial

An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients

Name: An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients — clinical trial record (NCT07142057)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the impact of the 23-valent pneumonia vaccine on the incidence of pulmonary infection and survival in lung cancer patients, and to explore its preventive effect and safety in the lung cancer patients.

Trial Details

NCT Number	NCT07142057
Lead Sponsor	The First Affiliated Hospital of Guangzhou Medical University
Conditions	LUNG CANCER
Enrollment	500 participants
Start Date	2025-09-01
Primary Completion	2027-09-01 (estimated)
Study Completion	2030-09-01 (estimated)
Updated on ClinicalTrials.gov	2025-08-26